lifetech scientific corp - LFTSF

LFTSF

Close Chg Chg %
0.23 -0.03 -14.35%

Closed Market

0.20

-0.03 (14.35%)

Volume: 10.00K

Last Updated:

Oct 26, 2026, 9:30 AM EDT

Company Overview: lifetech scientific corp - LFTSF

LFTSF Key Data

Open

$0.20

Day Range

0.20 - 0.20

52 Week Range

N/A - N/A

Market Cap

$1.05B

Shares Outstanding

4.04B

Public Float

3.35B

Beta

0.66

Rev. Per Employee

N/A

P/E Ratio

146.44

EPS

-$0.00

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

LFTSF Performance

1 Week
 
-14.35%
 
1 Month
 
N/A
 
3 Months
 
N/A
 
1 Year
 
N/A
 
5 Years
 
N/A
 

LFTSF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About lifetech scientific corp - LFTSF

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. It operates its business through the following segments: Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business. The Structural Heart Diseases Business segment offers trade, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is involved with the trade, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment focuses on trade, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The company was founded in 1999 and is headquartered in Shenzhen, China.

LFTSF At a Glance

LifeTech Scientific Corp.
LifeTech Scientific Building
Shenzhen, Guangdong 518057
Phone 86-755-8602-6250 Revenue 190.55M
Industry Medical Specialties Net Income 20.56M
Sector Health Technology 2025 Sales Growth 5.191%
Fiscal Year-end 12 / 2026 Employees 1,240
View SEC Filings

LFTSF Valuation

P/E Current 146.444
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 42.643
Price to Sales Ratio 4.647
Price to Book Ratio 1.663
Price to Cash Flow Ratio 11.17
Enterprise Value to EBITDA 21.281
Enterprise Value to Sales 3.721
Total Debt to Enterprise Value 0.002

LFTSF Efficiency

Revenue/Employee 153,671.623
Income Per Employee 16,584.292
Receivables Turnover 2.076
Total Asset Turnover 0.274

LFTSF Liquidity

Current Ratio 1.572
Quick Ratio 1.271
Cash Ratio 0.813

LFTSF Profitability

Gross Margin 72.973
Operating Margin 12.275
Pretax Margin 13.524
Net Margin 10.792
Return on Assets 2.962
Return on Equity 4.191
Return on Total Capital 4.082
Return on Invested Capital 4.188

LFTSF Capital Structure

Total Debt to Total Equity 0.229
Total Debt to Total Capital 0.228
Total Debt to Total Assets 0.16
Long-Term Debt to Equity 0.122
Long-Term Debt to Total Capital 0.121
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lifetech Scientific Corp - LFTSF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
162.96M 178.85M 181.15M 190.55M
Sales Growth
+13.58% +9.75% +1.28% +5.19%
Cost of Goods Sold (COGS) incl D&A
35.02M 40.17M 46.44M 51.50M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
8.93M 9.68M 10.96M 9.93M
Depreciation
7.02M 7.71M 9.09M 7.09M
Amortization of Intangibles
1.91M 1.97M 1.87M 2.84M
COGS Growth
+21.23% +14.73% +15.61% +10.89%
Gross Income
127.94M 138.68M 134.70M 139.05M
Gross Income Growth
+11.65% +8.39% -2.87% +3.23%
Gross Profit Margin
+78.51% +77.54% +74.36% +72.97%
2022 2023 2024 2025 5-year trend
SG&A Expense
81.04M 98.60M 110.91M 115.66M
Research & Development
29.25M 40.43M 40.55M 31.30M
Other SG&A
51.78M 58.17M 70.35M 84.36M
SGA Growth
+24.42% +21.67% +12.48% +4.29%
Other Operating Expense
- - - -
-
Unusual Expense
10.30M 25.73M 3.82M 4.28M
EBIT after Unusual Expense
36.60M 14.35M 19.98M 19.11M
Non Operating Income/Expense
19.90M 10.81M 8.03M 6.69M
Non-Operating Interest Income
2.47M 1.80M 2.58M 3.54M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
93.86K 101.91K 262.62K 29.21K
Interest Expense Growth
-76.80% +8.58% +157.71% -88.88%
Gross Interest Expense
93.86K 101.91K 262.62K 29.21K
Interest Capitalized
- - - -
-
Pretax Income
56.40M 25.06M 27.74M 25.77M
Pretax Income Growth
+8.98% -55.57% +10.71% -7.11%
Pretax Margin
+34.61% +14.01% +15.31% +13.52%
Income Tax
8.81M 9.61M 4.24M 11.00M
Income Tax - Current - Domestic
11.12M 12.49M 8.98M 12.17M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(2.32M) (2.88M) (4.74M) (1.17M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
47.33M 15.17M 23.41M 15.63M
Minority Interest Expense
(979.85K) (21.98M) (7.49M) (4.93M)
Net Income
48.31M 37.15M 30.90M 20.56M
Net Income Growth
+6.54% -23.10% -16.83% -33.45%
Net Margin Growth
+29.65% +20.77% +17.06% +10.79%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
48.31M 37.15M 30.90M 20.56M
Preferred Dividends
- - - -
-
Net Income Available to Common
48.31M 37.15M 30.90M 20.56M
EPS (Basic)
0.0114 0.0085 0.0071 0.0047
EPS (Basic) Growth
+8.57% -25.44% -16.47% -33.80%
Basic Shares Outstanding
4.23B 4.36B 4.38B 4.37B
EPS (Diluted)
0.011 0.0084 0.0071 0.0047
EPS (Diluted) Growth
+11.11% -23.64% -15.48% -33.80%
Diluted Shares Outstanding
4.41B 4.45B 4.39B 4.42B
EBITDA
55.84M 49.76M 34.76M 33.32M
EBITDA Growth
-4.05% -10.89% -30.14% -4.14%
EBITDA Margin
+34.26% +27.82% +19.19% +17.49%

Lifetech Scientific Corp in the News